Dasatinib-Induced Colitis with Rectal Sparing in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy: Case Report

Dasatinib is a BCR-ABL tyrosine kinase inhibitor which was approved in 2006 for the treatment of adults diagnosed with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP) and accelerated (myeloid or lymphoid blast) phase and CML with resistance or intolerance...

Descripción completa

Detalles Bibliográficos
Autores principales: Maat, Zakaria, Mushtaq, Kamran, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613618/
https://www.ncbi.nlm.nih.gov/pubmed/34899234
http://dx.doi.org/10.1159/000516794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613618/
https://www.ncbi.nlm.nih.gov/pubmed/34899234
http://dx.doi.org/10.1159/000516794

Ejemplares similares